News

September 25, 2019

William A. Kinney, PhD

September 25, 2019

Dean Petkanas

September 24, 2019

Michael Ropacki, PhD

September 23, 2019

Charles L. Loprinzi, MD

September 21, 2019

Daniele Piomelli, PhD, MD

September 21, 2019

Sara Jane Ward, PhD

September 17, 2019

Tage Honoré, Phd, DSc

June 27, 2019

Kannalife, Inc. to Present Breakthrough CIPN Study Findings on the Comparison of KLS-13019 to CBD at 29th Annual International Cannabinoid Research Society Conference

May 21, 2019

Kannalife Inc. Publishes New Research on Chemotherapy-Induced Peripheral Neuropathy

March 24, 2019

Kannalife Spokesman former NFL kicker Nick Lowery on Head Injuries, CBD Treatment

January 16, 2019

Kannalife Announces Completion of Name Change, Ticker Symbol Change

August 1, 2018

Kannalife Sciences Finalizes Share Exchange Agreement with TYG Solutions Corp.

June 26, 2018

Kannalife mentioned in BioSpace on the First Cannabis-Based Drug receives FDA Approval

May 22, 2018

Dateline NBC with Lester Holt profiles Kannalife on show “Growing Promise”

May 18, 2018

Kannalife Sciences to be Featured in Dateline NBC Segment Covering Company’s Research on CBD-Like Molecules as Treatments for HE, CTE

April 26, 2018

Former NFL great Nick Lowery talks Kannalife on CNBC

October 30, 2017

Kannalife Spokesman Nick Lowery on Between the Lines

September 28, 2017

Nick Lowery of Kannalife Speaks With Tiki and Tierney about CTE – CBS Sports

July 6, 2017

Kannalife Sciences Participates in 27th Annual International Cannabinoid Research Society (ICRS) Symposium Company Presents Science Behind Mechanism of Action of CBD and its Own Patented CBD-derived Molecule KLS-13019

April 29, 2015

CNN’s WEED3 with Dr. Sanjay Gupta features Kannalife and CEO Dean Petkanas

Get the Latest in Neuropathix News

Subscribe